245 unknown, 153 completed, 56 recruiting, 38 not yet recruiting. 204 Not applicable, 109 Phase 2, 54 Phase 1, 43 Phase 4, 27 Phase 3.
Follow Peking University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EMI for Reducing Psychological Distress in Young Adults With Multiple ACEs: A RCT Study EMI - Psychological Distress, Adverse Childhood Experience | Not applicable | Not yet recruiting | Peking University | 100 | 2026-10-19 | 2026-10-21 |
| EMI for Reducing Psychological Distress in Young Adults With Multiple ACEs: A Feasibility Study EMI - Psychological Distress, Adverse Childhood Experience | Not applicable | Not yet recruiting | Peking University | 20 | 2026-10-17 | 2026-10-16 |
| Fangshan Active Nutrition Initiative Digital Intelligence Platform-based Multi-level Weight Management - Childhood Weight Management | Not applicable | Not yet recruiting | Peking University | 1400 | 2026-09-20 | 2026-09-21 |
| Effects of an Exercise Snacking Intervention on Cognitive Function in Patients With Mild Cognitive Impairment: A Nationwide Multicenter Randomized Controlled Trial Baduanjin-Based Exercise Snacking - Mild Cognitive Impairment | Not applicable | Not yet recruiting | Peking University | 240 | 2026-09-15 | 2026-09-16 |
| The Dynamic Mechanism of Mindfulness Intervention for Emotional Distress (MIED) Based on Ecological Moment Measurement Mindfulness Intervention for emotional distress(MIED） - Emotional Distress, Depression | Not applicable | Not yet recruiting | Peking University | 100 | 2026-09-05 | 2026-09-09 |
| A Multicenter Real-World Study Evaluating the Efficacy and Safety of Shugan Jieyu Capsules in the Treatment of Depression Shugan Jieyu Capsules - Outpatients or Inpatients With Depression | Not applicable | Not yet recruiting | Peking University | 400 | 2026-09-01 | 2026-09-08 |
| Smart Analysis and Decision-Making for Emerging Infectious Diseases Multi-Agent Integrated Smart Toolkit for Emerging Infectious Diseases, Routine Practices - Emerging Infectious Diseases, COVID-19 | Not applicable | Enrolling by invitation | Peking University | 108 | 2026-08-10 | 2026-08-19 |
| A Blood Pressure-Lowering Diet for Preventing and Managing Hypertension Standard Hypertension Management, Eastern Blood Pressure-Lowering Diet - Hypertension | Not applicable | Not yet recruiting | Peking University | 800 | 2026-08-01 | 2026-07-29 |
| Mindfulness Intervention for Emotional Distress: An EEG Study MIED, PMR - Emotional Distress, Anxiety | Not applicable | Recruiting | Peking University | 160 | 2026-07-04 | 2026-09-08 |
| Time-Restricted Eating and Staple Food Reduction Combined With App-Supported Exercise for Weight and Glycemic Control App-Supported Exercise Intervention, Staple Food Reduction, Early Time-Restricted Eating - Obesity; Impaired Glucose Regulation; Prediabetes; Type 2 Diabetes Mellitus | Not applicable | Not yet recruiting | Peking University | 300 | 2026-07-01 | 2026-07-24 |
| Effects of Exercise Sequence and Meal Sequence on Weight Management Among Children and Adolescents With Overweight or Obesity: The STEP Trial Carbohydrate-last eating, Sequential training - Obesity & Overweight, Insulin Resistance | Not applicable | Not yet recruiting | Peking University | 480 | 2026-07-01 | 2026-07-17 |
| Botulinum Toxin Type A Injection Sites for Oral Commissure Ptosis OnabotulinumtoxinA (Upper Depressor Anguli Oris Injection), OnabotulinumtoxinA (Lower Depressor Anguli Oris Injection) - Facial Aging, Melomental Folds | Phase 4 | Not yet recruiting | Peking University | 266 | 2026-07-01 | 2026-07-07 |
| Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases Retlirafusp alfa Injection, Capecitabine, Oxaliplatin - Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma | Phase 3 | Not yet recruiting | Peking University | 332 | 2026-06-26 | 2026-06-30 |
| Salt Sensitivity Evaluation Via N-of-1 Trials (SENSE-Salt) High-Sodium Diet, Low-Sodium Diet - Salt-Sensitivity of Blood Pressure, Hypertension | Not applicable | Recruiting | Peking University | 72 | 2026-06-02 | 2026-08-31 |
| Digital Health Intervention for Early Identification and Prevention of Gestational Diabetes Mellitus Digital Health Lifestyle Intervention - Gestational Diabetes Mellitus (GDM) | Not applicable | Not yet recruiting | Peking University | 1200 | 2026-06-01 | 2026-03-30 |
| HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion HAIC, Lenvatinib, PD-1 Inhibitors - Hepatocellular Carcinoma (HCC) | Active not recruiting | Peking University | 150 | 2026-05-29 | 2026-06-09 | |
| AI-GF-GNW on Prolonged Grief Reactions AI-Assisted Grief-Focused Guided Narrative Writing, No-Feedback Guided Narrative Writing, Free Writing - Artificial Intelligence (AI), Prolonged Grief Symptoms | Not applicable | Not yet recruiting | Peking University | 126 | 2026-05-25 | 2026-05-15 |
| Effects of Digital Health Interventions on the Physical and Mental Health of Middle School Students Graphic-text Intervention, Video Intervention, AI Dialogue Intervention - Pediatric Obesity | Not applicable | Active not recruiting | Peking University | 800 | 2026-05-12 | 2026-05-28 |
| A Cluster-Randomized Trial of a Hypertension Risk Model-Based Precision Intervention in High-Risk Adults in Shunyi District Hypertension Risk Model-Based Precision Intervention, Standard Health Education - Hypertension | Not applicable | Recruiting | Peking University | 500 | 2026-04-01 | 2026-09-16 |
| HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer HAIC(GOLF), Bevacizumab, PD-1/PD-L1 inhibitor - Biliary Tract Cancer (BTC) | Not applicable | Recruiting | Peking University | 40 | 2026-03-31 | 2026-05-08 |
Showing 20 of 542. Sign in to see all of them.
Stomach Neoplasms (34) · Depression (20) · Obesity (18) · Esophageal Squamous Cell Carcinoma (17) · Breast Neoplasms (14) · Anxiety Disorders (12) · Hypertension (12) · Lymphoma (11) · Colorectal Neoplasms (9) · Diabetes Mellitus, Type 2 (9) · Cardiovascular Diseases (8) · Neuroendocrine Tumors (8) · Overweight (8) · Disease (7) · Hepatitis B (7)
Cisplatin (14) · Oxaliplatin (13) · Capecitabine (11) · Cyclophosphamide (11) · Fluorouracil (9) · Paclitaxel (9) · toripalimab (9) · Drug Therapy (8) · Irinotecan (8) · Bevacizumab (7) · Prednisone (7) · S 1 (combination) (7) · nimotuzumab (7) · Control Groups (5) · Surgical Procedures, Operative (5)
China (473) · United States (7) · South Korea (1) · Sweden (1)
Xinghua Liu (18) · Lin Shen, MD (10) · Jun Zhu, MD (7) · Lin Shen (7) · Lin Shen, Professor (6) · Jiafu Ji, M.D. (4) · Lin Shen, MD, PhD (4) · Xiaodong Wang, MD (4) · Yangfeng Wu, PhD (4) · Ziyu Li, MD (4) · Dajun Deng, MD (3) · Hong You, Doctor (3) · Jian-meng Liu, PhD (3) · Jun Zhu (3) · Liankun Ren, MD (3)
PMID 27641687, PMID 19671846, PMID 35788366, PMID 39373164, PMID 40108113, PMID 40658552, PMID 10636102, PMID 11057895, PMID 11172175, PMID 11215292, PMID 11777255, PMID 12094370, PMID 12375757, PMID 12531805, PMID 12538485, PMID 15042238, PMID 15512265, PMID 16098458, PMID 16112958, PMID 16293410, PMID 16445658, PMID 16445968, PMID 16516431, PMID 16550259, PMID 16710031, PMID 17046465, PMID 17435538, PMID 17435539, PMID 17544181, PMID 17617940, PMID 18235122, PMID 18724852, PMID 18724853, PMID 18790600, PMID 18930568, PMID 1894168, PMID 19095492, PMID 19245312, PMID 19357948, PMID 19374292, PMID 19514805, PMID 19515542, PMID 19656312, PMID 19727208, PMID 19748761, PMID 19853518, PMID 20346818, PMID 20571765, PMID 20868638, PMID 21182434
2015 (1), R01ES019616 (1), R01HD070821 (1), R01MH092225 (1)